Patents by Inventor Jayakanth Kankanala

Jayakanth Kankanala has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PYRROLE AND PYRAZOLE COMPOUNDS AND METHODS OF USE THEREOF
    Publication number: 20200239433
    Abstract: The disclosure relates to anti-cancer compounds derived from nuclear steroid receptor binders, to products containing the same, as well as to methods of their use and preparation.
    Type: Application
    Filed: November 27, 2019
    Publication date: July 30, 2020
    Inventors: Sarvajit Chakravarty, Son Minh Pham, Jiyun Chen, Jayakanth Kankanala, Jeremy D. Pettigrew, Anjan Kumar Nayak, Anup Barde, Brahmam Pujala
  • 1,8-NAPHTHYRIDINONE COMPOUNDS AND USES THEREOF
    Publication number: 20200231589
    Abstract: 1,8-naphthyridinone compounds as modulators of an adenosine receptor are provided. The compounds may find use as therapeutic agents for the treatment of diseases mediated through a G-protein-coupled receptor signaling pathway and may find particular use in oncology.
    Type: Application
    Filed: January 17, 2020
    Publication date: July 23, 2020
    Inventors: Son Minh PHAM, Jayakanth KANKANALA, Pradeep S. JADHAVAR, Baban Mohan MULIK, Farha KHAN, Sreekanth A. RAMACHANDRAN
  • HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS
    Publication number: 20200231570
    Abstract: Aminopyrazine compounds as modulators of an adenosine receptor are provided. The compounds may find use as therapeutic agents for the treatment of diseases mediated through a G-protein-coupled receptor signaling pathway and may find particular use in oncology.
    Type: Application
    Filed: January 17, 2020
    Publication date: July 23, 2020
    Inventors: Son Minh PHAM, Jayakanth KANKANALA, Pradeep S. JADHAVAR, Baban Mohan MULIK, Farha KHAN, Sreekanth A. RAMACHANDRAN
  • DIARYLHYDANTOIN COMPOUNDS AND METHODS OF USE THEREOF
    Publication number: 20200199098
    Abstract: The disclosure relates to anti-cancer compounds derived from nuclear steroid receptor binders, to products containing the same, as well as to methods of their use and preparation.
    Type: Application
    Filed: November 27, 2019
    Publication date: June 25, 2020
    Inventors: Sarvajit Chakravarty, Son Minh Pham, Jiyun Chen, Jayakanth Kankanala, Jeremy D. Pettigrew, Anjan Kumar Nayak, Anup Barde, Brahmam Pujala
  • HETEROCYCLIC COMPOUNDS AS BET INHIBITORS
    Publication number: 20200140459
    Abstract: Novel bromodomain and extraterminal domain (BET) inhibitors and to therapeutic methods of treating conditions and diseases using these novel BET inhibitors are provided.
    Type: Application
    Filed: October 30, 2019
    Publication date: May 7, 2020
    Inventors: Son Minh PHAM, Sarvajit CHAKRAVARTY, Jayakanth KANKANALA, Jiyun CHEN, Anjan Kumar NAYAK, Anup BARDE
  • Compounds for cancer chemotherapeutic sensitization
    Patent number: 10617706
    Abstract: The invention provides a compound of formula (I), (II) or (III): wherein R1, R2, R3, R4 and R5 have any of the values described in the specification, as well as compositions comprising a compound of formula (I), (II) or (III). The compounds and compositions are useful as chemotherapeutic sensitizing agents.
    Type: Grant
    Filed: February 4, 2019
    Date of Patent: April 14, 2020
    Assignees: REGENTS OF THE UNIVERSITY OF MINNESOTA, THE USA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES
    Inventors: Zhengqiang Wang, Jayakanth Kankanala, Yves Pommier
  • HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS
    Publication number: 20190248774
    Abstract: Heterocyclic compounds as CDK4 or CDK6 or other CDK inhibitors are provided. The compounds may find use as therapeutic agents for the treatment of diseases and may find particular use in oncology.
    Type: Application
    Filed: February 15, 2019
    Publication date: August 15, 2019
    Inventors: Son Minh PHAM, Sarvajit CHAKRAVARTY, Jayakanth KANKANALA, Brahmam PUJALA, Amit SHETE, Bhawana BHATT, Anil Kumar AGARWAL, Sanjeev SONI, Jiyun CHEN
  • COMPOUNDS FOR CANCER CHEMOTHERAPEUTIC SENSITIZATION
    Publication number: 20190240244
    Abstract: The invention provides a compound of formula (I), (II) or (III): wherein R1, R2, R3, R4 and R5 have any of the values described in the specification, as well as compositions comprising a compound of formula (I), (II) or (III). The compounds and compositions are useful as chemotherapeutic sensitizing agents.
    Type: Application
    Filed: February 4, 2019
    Publication date: August 8, 2019
    Inventors: Zhengqiang Wang, Jayakanth Kankanala, Yves Pommier
  • HETEROCYCLIC COMPOUNDS AND USES THEREOF
    Publication number: 20190106436
    Abstract: Heterocyclic compounds as Wee1 inhibitors are provided. The compounds may find use as therapeutic agents for the treatment of diseases and may find particular use in oncology.
    Type: Application
    Filed: October 9, 2018
    Publication date: April 11, 2019
    Inventors: Sarvajit Chakravarty, Son Minh PHAM, Jayakanth Kankanala, Anil Kumar AGARWAL, Brahmam PUJALA, Sanjeev SONI, Satish K. ARYA, Deepak PALVE, Varun KUMAR
  • HETEROCYCLIC COMPOUNDS AND USES THEREOF
    Publication number: 20190106427
    Abstract: Heterocyclic compounds as Wee1 inhibitors are provided. The compounds may find use as therapeutic agents for the treatment of diseases and may find particular use in oncology.
    Type: Application
    Filed: October 9, 2018
    Publication date: April 11, 2019
    Inventors: Sarvajit Chakravarty, Son Minh PHAM, Jayakanth Kankanala, Anil Kumar AGARWAL, Brahmam PUJALA, Sanjeev SONI, Satish K. ARYA, Deepak PALVE, Ashu Gupta, Varun KUMAR